InspireMD, Inc. (NSPR) Stock Analysis & Investment Frameworks
InspireMD, Inc. (NSPR) stock analysis on Invetso. Review InspireMD, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
InspireMD, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
InspireMD, Inc. Key Financial Metrics
- Market Cap: $21.76M
- Revenue: $8.98M
- ROE: -79.21%
- ROIC: -153.04%
- Dividend Yield: N/A
About InspireMD, Inc.
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.
InspireMD, Inc. Investment Frameworks
Invetso analyzes InspireMD, Inc. (NSPR) across the following frameworks:
- InspireMD, Inc. 10Y Growth Potential
- InspireMD, Inc. Scenario Analysis
- InspireMD, Inc. Risks & Opportunities
- InspireMD, Inc. Economic Moat
- InspireMD, Inc. Business Model
- InspireMD, Inc. Management
- InspireMD, Inc. SWOT Analysis
- InspireMD, Inc. Porter's 5 Forces
- InspireMD, Inc. PESTLE Analysis
- InspireMD, Inc. ESG Analysis